(Q37707255)

22 August 2017

1 reference

title

Head and neck cancer: response to p53-based therapeutics (English)

1 reference

22 August 2017

1 reference

1 reference

head and neck carcinoma

1 reference

Jackie Nemunaitis

1

1 reference

PubMed ID

20222046

22 August 2017

John Nemunaitis

series ordinal

2

1 reference

22 August 2017

1 January 2011

1 reference

22 August 2017

1 reference

22 August 2017

33

1 reference

22 August 2017

131-134

1 reference

22 August 2017

1

1 reference

End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

22 August 2017

1 reference

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

A review on re-irradiation for recurrent and second primary head and neck cancer

21 January 2018

1 reference

Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies

21 January 2018

1 reference

Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors

21 January 2018

1 reference

The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies

21 January 2018

1 reference

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

21 January 2018

1 reference

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

Cell cycle control and cancer

21 January 2018

1 reference

P53, cell cycle control and apoptosis: implications for cancer

21 January 2018

1 reference

On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damage

21 January 2018

1 reference

The p53 tumour suppressor gene

21 January 2018

1 reference

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.

21 January 2018

1 reference

Genomics and proteomics in cancer

21 January 2018

1 reference

The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones

21 January 2018

1 reference

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

21 January 2018

1 reference

7 January 2021

Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

7 January 2021

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

1 reference

7 January 2021

Safety evaluation of Ad5CMV-p53 in vitro and in vivo

1 reference

7 January 2021

Cancer genetics or cancer genomics in the era of genomic medicine?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21364

1 reference

22 August 2017

1 reference

PubMed ID

20222046